RENO, Nev.--(BUSINESS WIRE)--Feb. 28, 2006--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) announces that Dr. Kefah Mokbel has joined its Medical Advisory Board. He assisted in the introduction of the MastaScope(TM) at the European Breast Cancer Conference in Hamburg, Germany in 2004. Recently, Dr. Mokbel and his colleagues caused the initial testing of the OvaScope(TM) to assist in the early detection of ovarian cancer.
